ANEW Medical PE Ratio 2023-2024 | KLTO
Current and historical p/e ratio for ANEW Medical (KLTO) from 2023 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ANEW Medical PE ratio as of September 18, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| ANEW Medical PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2024-09-18 |
0.89 |
|
inf |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.016B |
$0.000B |
|
ANEW MEDICAL INC. specializes in the development of diagnostics and novel disease-modifying therapies for neurological and age-related disorders. The company's focus on central nervous systems diseases utilizing cell and gene therapies to mitigate age-related pathologies such as Alzheimer's disease, dementia symptoms and neuromuscular diseases. ANEW MEDICAL INC., formerly known as REDWOODS ACQ, is based in NEW YORK.
|
